Virus News and Research

Latest Virus News and Research

Seizures as a main manifestation of severe pediatric SARS-CoV-2 infection

A new study aimed to investigate the clinical, demographic, laboratory, neurophysiological, and imaging characteristics of children admitted to the ED with seizures and acute SARS-CoV-2 infection.

8 Sep 2021

Scientists model the process of capsid disassembly in hepatitis B virus at atomic level

With up to 2.4 million U.S. cases and over 250 million chronic cases globally, hepatitis B infection persists despite the availability of a vaccine.

8 Sep 2021

Researchers say modified COVID-19 vaccine boosters should control pandemic

Researchers in Texas have provided evidence for the need to modify the currently used coronavirus disease 2019 (COVID-19) vaccines to match circulating variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

8 Sep 2021

Potential pancoronavirus fusion inhibitors that are effective against SARS-CoV-2 variants

A new study successfully identifies a series of inhibitors that possesses pancoronavirus activity against SARS-CoV, SARS-CoV-2, and MERS-CoV.

7 Sep 2021

Highly neutralizing human convalescent plasma reduces lung inflammation in SARS-CoV-2-infected macaques

A new study reignites the debate regarding the therapeutic utility of convalescent plasma in treating others with the COVID-19.

7 Sep 2021

COVID-19 vaccine antibodies inversely related to BMI in obese men, but not women

A new study discusses the role of obesity in COVID-19 and its role in antibody-mediated immune responses to the COVID-19 vaccine.

7 Sep 2021

Activated mast cell disorders potentially linked to SARS-CoV-2 immunity

An intriguing new study reports a year-long study in patients with cMCADs from all over France.

7 Sep 2021

A study of 105 protective and risk factors related to the incidence and severity of COVID-19

A recent study discusses both the known and unknown factors that may affect the risk of infection with SARS-CoV-2 and a severe course of COVID-19.

7 Sep 2021

Optical biosensors enable fast, accurate, point-of-care COVID-19 diagnosis

Without the prospect of herd immunity on the immediate horizon, speedy detection for COVID-19 remains imperative for helping to curb the pandemic. Point-of-care testing that can provide immediate results is an urgent need.

7 Sep 2021

Study offers important evidence for the safety of stem cell transplants

Stem cell transplants do not lead to changes in the DNA of the donor cells. That's according to a new study, which provides important evidence for the safety of this procedure.

7 Sep 2021

Study could help improve design, fabrication, and use of nanofiber face masks

Since its outbreak, the COVID-19 virus has infected more than 207.7 million people worldwide and has claimed more than 4.3 million lives, according to the World Health Organization coronavirus dashboard as of Aug. 17.

7 Sep 2021

Four in five adults across the UK have received both doses of COVID-19 vaccine

Four in five people aged 16 and over in the UK have received both doses of a COVID-19 vaccine, the latest figures show.

7 Sep 2021

Effects of non-pharmaceutical interventions and mutations on COVID-19 resurgence

A recent study addresses the effects of controlling non-pharmaceutical interventions to develop a deeper understanding of their influence on the resurgence of COVID-19.

7 Sep 2021

High COVID-19 vaccine effectiveness in Israeli HCP

A study aimed to evaluate the VE against SARS-CoV-2 infection by carrying out a prospective cohort study that included healthcare personnel (HCP) in six hospitals in Israel.

7 Sep 2021

COVID-19 infection does not appear to affect the lung function of young adults, finds study

COVID-19 infection does not appear to affect the lung function of young adults, according to new research presented at the 'virtual' European Respiratory Society International Congress today (Tuesday).

7 Sep 2021

Vesicular stomatitis virus-based COVID vaccines demonstrate potent antiviral efficacy against SARS-CoV-2 variants

Scientists from the National Institutes of Health, USA, have recently demonstrated the immunogenicity and protective efficacy of two vesicular stomatitis virus (VSV)-based coronavirus disease 2019 (COVID-19) vaccines in hamsters.

6 Sep 2021

Multiplexed electrochemical sensor platform enables simultaneous detection of SARS-CoV-2 RNA and host antibodies

Scientists from the UK and USA have developed an antifouling nanocomposite-coated multiplexed electrochemical sensor platform that can simultaneously detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA and virus-specific antibodies. The platform has shown 100% accuracy in detecting viral RNA and IgG-specific anti-SARS-CoV-2 antibodies. The study is currently available on the medRxiv* preprint server.

6 Sep 2021

Implications of persistent SARS-CoV-2 infection in patients with lymphoid malignancies

In a recent study, scientists attempt to understand persistent COVID-19 and its implications in patients with hematologic malignancies.

6 Sep 2021

Study sheds light on neurologic symptoms caused by SARS-CoV-2 infection

Researchers in Australia and Finland have provided important insights into how infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – might affect nervous system circuitries and cause neurologic symptoms.

6 Sep 2021

Study reveals Pfizer/BioNTech and Oxford/AstraZeneca COVID-19 vaccine efficacy and immune response in clinically vulnerable individuals

The current study found that a strong S-antibody response occurs following complete vaccination with two different COVID-19 vaccines.

6 Sep 2021

Virus News and Research

Latest Virus News and Research

Seizures as a main manifestation of severe pediatric SARS-CoV-2 infection

Scientists model the process of capsid disassembly in hepatitis B virus at atomic level

Researchers say modified COVID-19 vaccine boosters should control pandemic

Potential pancoronavirus fusion inhibitors that are effective against SARS-CoV-2 variants

Highly neutralizing human convalescent plasma reduces lung inflammation in SARS-CoV-2-infected macaques

COVID-19 vaccine antibodies inversely related to BMI in obese men, but not women

Activated mast cell disorders potentially linked to SARS-CoV-2 immunity

A study of 105 protective and risk factors related to the incidence and severity of COVID-19

Optical biosensors enable fast, accurate, point-of-care COVID-19 diagnosis

Study offers important evidence for the safety of stem cell transplants

Study could help improve design, fabrication, and use of nanofiber face masks

Four in five adults across the UK have received both doses of COVID-19 vaccine

Effects of non-pharmaceutical interventions and mutations on COVID-19 resurgence

High COVID-19 vaccine effectiveness in Israeli HCP

COVID-19 infection does not appear to affect the lung function of young adults, finds study

Vesicular stomatitis virus-based COVID vaccines demonstrate potent antiviral efficacy against SARS-CoV-2 variants

Multiplexed electrochemical sensor platform enables simultaneous detection of SARS-CoV-2 RNA and host antibodies

Implications of persistent SARS-CoV-2 infection in patients with lymphoid malignancies

Study sheds light on neurologic symptoms caused by SARS-CoV-2 infection

Study reveals Pfizer/BioNTech and Oxford/AstraZeneca COVID-19 vaccine efficacy and immune response in clinically vulnerable individuals

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in